Companies: 10,795·Total market cap: $144.5T
Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

CDIONASDAQHealthcare● Active
$1.99
+$0.03(+1.53%)
Market Cap$4120544
P/E Ratio
52W High$7.91
52W Low$0.97
SEC Filings

Cardio Diagnostics Holdings, Inc. (CDIO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001870144 · CDIO · NASDAQ · as of Jun 8, 2026

Filing snapshot

279
Total Filings
10-Q
Latest Form
2026-05-15
Most Recent
2022
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001870144 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-13
Fiscal Year End
Mar 13, 2026
Accession No.
0001553350-26-000023
Primary Document
cdio_10k-123125.htm
Source: data.sec.gov · CIK 0001870144 · Accession 0001553350-26-000023

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
8-KCurrent Report
FORM 8-K
2026-02-19Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
View
10-KAnnual Report
ANNUAL REPORT
2026-03-13
View
8-KCurrent Report
FORM 8-K
2026-02-19
View
10-QQuarterly Report
FORM 10-Q
2025-11-12
View
8-KCurrent Report
FORM 8-K
2025-10-15
View
424B3424B3
PROSPECTUS
2025-09-23
View
EFFECTEFFECT
EFFECT
2025-09-19
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1
2025-09-16
View
424B3424B3
FINAL PROSPECTUS
2025-09-12
View
EFFECTEFFECT
EFFECT
2025-09-09
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 3
2025-09-05
View
DEFA14AProxy Statement (Additional)
DEFINITIVE 14A ADDITIONAL MATERIALS
2025-09-04
View
DEF 14AProxy Statement
DEFINITIVE 14A
2025-09-04
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2025-08-27
View
10-QQuarterly Report
FORM 10-Q
2025-08-14
View
Showing 1–15 of 192 filingsForm 4 / 144 hidden· 279 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001870144  |  Exchange: NASDAQ · Healthcare

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) has submitted 279 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001870144, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Cardio Diagnostics Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Cardio Diagnostics Holdings, Inc. 10-K was filed on 2026-03-13 for fiscal year ending 2026. Historical CDIO 10-K annual reports are available from 2021 through 2026.

Investors researching Cardio Diagnostics Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

CDIO SEC Filings · 8 questions

Cardio Diagnostics Holdings, Inc. (CDIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 279 filings and access original documents at no cost. Cardio Diagnostics Holdings, Inc.'s CIK is 0001870144.

CDIO SEC filingsCardio Diagnostics Holdings, Inc. SEC documentsfind CDIO 10-K